Top Markets
#1 DogBull DogBull +105.02%
#2 Siacoin Siacoin +50.45%
#3 MarsCoin MarsCoin +49.07%
#4 ADO Protocol ADO Protocol +46.44%
#5 UnifAI Network UnifAI Network +44.79%
#6 Ontology Gas Ontology Gas +25.91%
#7 Useless Coin Useless Coin +23.08%
#8 Magma Finance Magma Finance +22.65%
#9 Cash Cat Cash Cat +16.86%
#10 Apertum Apertum +13.60%
Coin of the day
DogBull DogBull
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Clover Biopharmaceuticals, Ltd. Clover Biopharmaceuticals, Ltd.

Clover Biopharmaceuticals, Ltd.

2197
Rankning i aktier #15708
Clover Biopharmaceuticals, Ltd. is a biotechnology enterprise focused on... Clover Biopharmaceuticals, Ltd. is a biotechnology enterprise focused on discovering, developing, and commercializing innovative vaccines and biological therapies. Their efforts target infectious diseases, various cancers, and autoimmune conditions. The company's pipeline features several key candidates: SCB-2019 (CpG 1018/Alum): A COVID-19 vaccine candidate currently advancing through Phase II/III clinical trials. SCB-313: A trimeric fusion protein aimed at treating severe intracavitary malignancies, including malignant ascites, malignant pleural effusions, and peritoneal carcinomatosis, addressing a significant global medical need. SCB-808: Undergoing pivotal Phase III clinical trials for the management of rheumatic disorders. SCB-420: An aflibercept biosimilar in preclinical development for ophthalmologic conditions like wet age-related macular degeneration. SCB-219: A novel TPOR agonist in preclinical stages for the treatment of chemotherapy-induced thrombocytopenia and immune thrombocytopenic purpura. Clover also holds a collaboration and supply agreement with Dynavax, which provides its CpG 1018 adjuvant for use in preclinical studies. The company was established in 2007 and is based in Shanghai, China.
Aktiekurs
$0.25841098
Marknadsvärde
$335.38M
Förändring (1 dag)
-2.42%
Förändring (1 år)
73.70%
Land
CN
Handel Clover Biopharmaceuticals, Ltd. (2197)

Kategori

Healthcare
Utdelningshistorik för Clover Biopharmaceuticals, Ltd. (2197)
Clover Biopharmaceuticals, Ltd. (aktiens symbol: 2197) har gjort totalt 0 utdelningsbetalningar.
Summan av alla utdelningar (justerat för aktiesplitar) är: 0.00
Utdelningsavkastning (TTM): 0
Utdelningsbetalningar för Clover Biopharmaceuticals, Ltd. (2197) från 2026 till 2026
Årliga utdelningsbetalningar
År Utdelning (justerat för aktiesplitar) Ändra
Inte tillräckligt med data för de angivna datumen.
Lista över alla utdelningsbetalningar
År Utdelning Ändra
Inte tillräckligt med data för de angivna datumen.
Utdelningar för liknande företag eller konkurrenter
Företag Antal utdelningsbetalningar Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH